Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 113

Similar articles for PubMed (Select 16135526)

1.

Activity of posaconazole in the treatment of central nervous system fungal infections.

Pitisuttithum P, Negroni R, Graybill JR, Bustamante B, Pappas P, Chapman S, Hare RS, Hardalo CJ.

J Antimicrob Chemother. 2005 Oct;56(4):745-55. Epub 2005 Aug 31.

2.

Posaconazole: an extended-spectrum triazole antifungal agent.

Schiller DS, Fung HB.

Clin Ther. 2007 Sep;29(9):1862-86. Review.

PMID:
18035188
3.

Successful therapy of cerebral phaeohyphomycosis due to Ramichloridium mackenziei with the new triazole posaconazole.

Al-Abdely HM, Alkhunaizi AM, Al-Tawfiq JA, Hassounah M, Rinaldi MG, Sutton DA.

Med Mycol. 2005 Feb;43(1):91-5. Review.

PMID:
15712614
4.

Posaconazole.

Keating GM.

Drugs. 2005;65(11):1553-67; discussion 1568-9. Review.

PMID:
16033292
5.

Treatment of invasive aspergillosis with posaconazole in patients who are refractory to or intolerant of conventional therapy: an externally controlled trial.

Walsh TJ, Raad I, Patterson TF, Chandrasekar P, Donowitz GR, Graybill R, Greene RE, Hachem R, Hadley S, Herbrecht R, Langston A, Louie A, Ribaud P, Segal BH, Stevens DA, van Burik JA, White CS, Corcoran G, Gogate J, Krishna G, Pedicone L, Hardalo C, Perfect JR.

Clin Infect Dis. 2007 Jan 1;44(1):2-12. Epub 2006 Nov 28.

6.

Posaconazole as salvage therapy in patients with invasive fungal infections after solid organ transplant.

Alexander BD, Perfect JR, Daly JS, Restrepo A, Tobón AM, Patino H, Hardalo CJ, Graybill JR.

Transplantation. 2008 Sep 27;86(6):791-6. doi: 10.1097/TP.0b013e3181837585.

PMID:
18813103
7.

A multicenter, open-label study of posaconazole oral suspension in the treatment of invasive fungal infections in patients refractory to or intolerant of first-line therapy.

Huang X, Wang F, Chen Y, Liu T, Wang J, Hu J, Jie J, Chen F, Wang S, Shen Z, Yu L, Yu K, Liang Y.

Future Microbiol. 2012 Feb;7(2):201-9. doi: 10.2217/fmb.11.158.

PMID:
22324990
8.

[The latest data on posaconazole].

Paugam A.

Med Mal Infect. 2007 Feb;37(2):71-6. Epub 2007 Jan 30. Review. French.

PMID:
17267154
9.

Posaconazole as salvage therapy for zygomycosis.

Greenberg RN, Mullane K, van Burik JA, Raad I, Abzug MJ, Anstead G, Herbrecht R, Langston A, Marr KA, Schiller G, Schuster M, Wingard JR, Gonzalez CE, Revankar SG, Corcoran G, Kryscio RJ, Hare R.

Antimicrob Agents Chemother. 2006 Jan;50(1):126-33.

10.

Posaconazole as salvage treatment of invasive fungal infections in patients with underlying renal impairment.

Hachem RY, Langston AA, Graybill JR, Perfect JR, Pedicone LD, Patino H, Raad II.

J Antimicrob Chemother. 2008 Dec;62(6):1386-91. doi: 10.1093/jac/dkn401. Epub 2008 Oct 3.

11.

Posaconazole: a new broad-spectrum antifungal agent.

Kwon DS, Mylonakis E.

Expert Opin Pharmacother. 2007 Jun;8(8):1167-78. Review.

PMID:
17516880
12.

Refractory coccidioidomycosis treated with posaconazole.

Anstead GM, Corcoran G, Lewis J, Berg D, Graybill JR.

Clin Infect Dis. 2005 Jun 15;40(12):1770-6. Epub 2005 May 13.

13.
14.

Posaconazole: clinical pharmacology and potential for management of fungal infections.

Groll AH, Walsh TJ.

Expert Rev Anti Infect Ther. 2005 Aug;3(4):467-87. Review.

PMID:
16107193
15.

Posaconazole treatment of refractory eumycetoma and chromoblastomycosis.

Negroni R, Tobón A, Bustamante B, Shikanai-Yasuda MA, Patino H, Restrepo A.

Rev Inst Med Trop Sao Paulo. 2005 Nov-Dec;47(6):339-46.

PMID:
16553324
16.

Posaconazole plasma concentrations in juvenile patients with invasive fungal infection.

Krishna G, Sansone-Parsons A, Martinho M, Kantesaria B, Pedicone L.

Antimicrob Agents Chemother. 2007 Mar;51(3):812-8. Epub 2007 Jan 8.

17.

The role of voriconazole in the treatment of central nervous system blastomycosis.

Ta M, Flowers SA, Rogers PD.

Ann Pharmacother. 2009 Oct;43(10):1696-700. doi: 10.1345/aph.1M010. Epub 2009 Sep 1. Review.

PMID:
19724015
18.

Posaconazole as salvage treatment for invasive fusariosis in patients with underlying hematologic malignancy and other conditions.

Raad II, Hachem RY, Herbrecht R, Graybill JR, Hare R, Corcoran G, Kontoyiannis DP.

Clin Infect Dis. 2006 May 15;42(10):1398-403. Epub 2006 Apr 11.

19.

Salvage therapy with voriconazole for invasive fungal infections in patients failing or intolerant to standard antifungal therapy.

Baden LR, Katz JT, Fishman JA, Koziol C, DelVecchio A, Doran M, Rubin RH.

Transplantation. 2003 Dec 15;76(11):1632-7.

PMID:
14702539
20.

Liposomal amphotericin B: a review of its use as empirical therapy in febrile neutropenia and in the treatment of invasive fungal infections.

Moen MD, Lyseng-Williamson KA, Scott LJ.

Drugs. 2009;69(3):361-92. doi: 10.2165/00003495-200969030-00010. Review.

PMID:
19275278
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk